Skip to main content
Premium Trial:

Request an Annual Quote

New Indiana Cardiology Institute to Use IU s Genomic, Proteomic Resources

NEW YORK, March 22 (GenomeWeb News) - A new public/private non-profit organization will use the genomic and proteomic research facilities at the Indiana University School of Medicine to conduct heart disease studies, BioCrossroads, which co-founded the entity with IU, said yesterday.


The organization, called the Fairbanks Institute, will coordinate a long-term health study integrating patient data to focus efforts on heart disease prevention and treatment. It will focus on other diseases as well, with the help of a $10 million start-up donation from the Fairbanks Foundation.


The institute will take advantage of Indiana University's genomic and proteomic divisions and of the Indiana Genomics Initiative, according to a statement.


It will also collaborate with the public-private collaboration BioCrossroads and with the Regenstrief Institute.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.